山东大学耳鼻喉眼学报 ›› 2016, Vol. 30 ›› Issue (5): 110-114.doi: 10.6040/j.issn.1673-3770.0.2016.322

• 论著 • 上一篇    下一篇

RNAi沉默PDCD4基因对人喉癌Hep-2细胞增殖及β-catenin表达的影响

许元腾1,陈瑞庆2,林功标1,方秀玲1,俞舒娟1,梁晓华3,张榕1   

  1. 福建医科大学附属第一医院 1.耳鼻咽喉科;
    2.中心实验室;
    3.检验科, 福建 福州 350005
  • 收稿日期:2016-07-20 出版日期:2016-10-20 发布日期:2016-10-20
  • 通讯作者: 林功标. E-mail: lingongbiao@qq.com; 张榕. E-mail:zhang2012rong@sina.cn E-mail:xyt973@163.co
  • 作者简介:许元腾. E-mail:xyt973@163.co
  • 基金资助:
    福建省自然科学基金(2014j01311);福建省财政厅专项基金［闽财指(2015)1297号］

Effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique.

XU Yuanteng1, CHEN Ruiqing2, LIN Gongbiao1, FANG Xiuling1, YU Shujuan1, LIANG Xiaohua3, ZHANG Rong   

  1. 1. Department of Otolaryngology;2. Central Laboratory;3. Clinical Laboratory, The First Affliated Hospital of Fujian Medical University, Fuzhou 350005, Fujian, China
  • Received:2016-07-20 Online:2016-10-20 Published:2016-10-20

PDF (PC)

890

被引次数

2

摘要： 目的 应用RNAi技术下调人喉癌Hep-2细胞中PDCD4基因的表达,探讨其对Hep-2细胞增殖及β-catenin表达的影响。 方法 设计并合成针对PDCD4基因的shRNA质粒与阴性对照质粒,分别转染Hep-2细胞。实时定量RT-PCR和Western blotting检测转染前后阴性对照组与干扰组PDCD4、β-catenin基因mRNA和蛋白的表达。克隆形成实验观察Hep-2细胞增殖能力的变化。 结果 与对照组相比,PDCD4干扰组的Hep-2细胞克隆形成率显著升高(P=0.01),PDCD4干扰组PDCD4mRNA和蛋白均显著减低(P<0.01)、β-catenin mRNA和蛋白均较对照组显著增加(P<0.01)。 结论 成功应用RNAi技术下调人喉癌Hep-2细胞中PDCD4基因的表达,Hep-2细胞克隆形成能力增强,β-catenin mRNA和蛋白表达显著升高。

关键词: RNA干扰, 喉癌, Hep-2细胞, β-catenin, 细胞增殖, PDCD4基因

Abstract: Objective To study the effect of silencing PDCD4 gene on proliferation of Hep-2 cells and the expression of β-catenin by RNA interference technique. Methods Specific shRNA plasmid and negative control plasmid of PDCD4 gene were designed and synthesized. Hep-2 cells were transfected with shRNA plasmid and negative control plasmid. Real-time RT-PCR and Western blotting analysis were performed to determine the expressions of PDCD4 and β-catenin mRNA and protein after transfection, respectively. The proliferation of Hep-2 cells was observed by colony-forming assay. Results Compared to the control group, the colony formation rate of Hep-2 cells was significantly increased in the shRNNA plasmid group(P=0.01); the expressions of PDCD4 mRNA and protein were significantly reduced(P<0.01);the expressions of β-catenin mRNA and protein were significantly increased(P<0.01). Conclusion RNA interference technique can effectively silence PDCD4 gene expression of Hep-2 cells,enhance the colony forming ability of Hep-2 and increase the expressions of β-catenin mRNA and protein.

Key words: Hep-2 cell, PDCD4 gene, β-catenin, Cell proliferation, Laryngeal cancer, RNA interference

中图分类号: 

  • R739.65
[1] Ferlay J, Shin H R, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer, 2010, 127(12): 2893-2917.
[2] Shangina O, Brennan P, Szeszenia-Dabrowska N, et al. Occupational exposure and laryngeal and hypopharyngeal cancer risk in central and eastern Europe[J]. Am J Epidemiol, 2006, 164(4): 367-375.
[3] Gao X, Fisher S G, Mohideen N, et al. Second primary cancers in patients with laryngeal cancer: a population-based study[J]. Int J Radiat Oncol Biol Phys, 2003, 56(2): 427-435.
[4] Marioni G, Marchese-Ragona R, Cartei G, et al. Current opinion in diagnosis and treatment of laryngeal carcinoma[J]. Cancer Treat Rev, 2006, 32(7): 504-515.
[5] Wang Q, Zhu J, Zhang Y, et al. Down-regulation of programmed cell death 4 leads to epithelial to mesenchymal transition and promotes metastasis in mice[J]. Eur J Cancer, 2013, 49(7): 1761-70.
[6] 冯国飞, 李培华, 尤慧华, 等. 喉癌组织中程序性细胞死亡因子4的表达及临床意义[J]. 临床耳鼻咽喉头颈外科杂志, 2011, 25(1): 16-19. FENG Guofei, LI Peihua, YOU Huihua, et al. The expression and clinical pathological significance of PDCD in laryngocarcinoma[J]. J Clin Otorhinolaryngol Head Neck Surgery, 2011, 25(1): 16-19.
[7] Shibahara K, Asano M, Ishida Y, et al. Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death[J]. Gene, 1995, 166(2): 297-301.
[8] Wedeken L, Ohnheiser J, Hirschi B, et al. Association of Tumor Suppressor Protein Pdcd4 With Ribosomes Is Mediated by Protein-Protein and Protein-RNA Interactions[J]. Genes Cancer, 2010, 1(3): 293-301.
[9] Wen Y H, Shi X, Chiriboga L, et al. Alterations in the expression of PDCD4 in ductal carcinoma of the breast[J]. Oncol Rep, 2007, 18(6): 1387-1393.
[10] Zhang H, Ozaki I, Mizuta T, et al. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma[J]. Oncogene, 2006, 25(45): 6101-6112.
[11] Chen Y, Kn(¨overo)sel T, Kristiansen G, et al. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis[J]. J Pathol, 2003, 200(5): 640-646.
[12] 纪旭, 李虹, 符静, 等. PDCD4在喉癌中的表达及意义[J]. 解剖科学进展, 2014, 20(3): 273-275. JI Xu, LI Hong, FU Jing, et al. Expression and significance of PDCD4 in human laryngeal squamous cell carcinoma[J]. Prog Anat Sci, 2014, 20(3):273-275.
[13] Mudduluru G, Medved F, Grobholz R, et al. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer[J]. Cancer, 2007, 110(8): 1697-1707.
[14] Wang Q, Sun Z, Yang H S. Downregulation of tumor suppressor Pdcd4 promotes invasion and activates both beta-catenin/Tcf and AP-1-dependent transcription in colon carcinoma cells[J]. Oncogene, 2008, 27(11): 1527-1535.
[15] 于锋, 黄鑫, 林颖, 等. siRNA下调β-catenin基因对喉癌Hep-2细胞增殖、凋亡和侵袭的影响[J]. 中国耳鼻咽喉头颈外科,2015,22(7): 329-333. YU Feng, HUANG Xin, LIN Ying, et al. Effect of siRNA downregulation of β-catenin on proliferation, apoptosis and invasion of laryngeal carcinoma Hep-2 cells[J]. Chin Arch Otolaryngol Head Neck Surgery, 2015,22(7): 329-333.
[16] Macdonald B T, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, and diseases[J]. Developmental Cell, 2009, 17(1):9-26.
[17] Wang Q, Sun Z X, Allgayer H, et al. Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells[J]. Oncogene, 2010, 29(1):128-138.
[18] Pietruszewska W, Kobos J, Gryczyński M. [Expression of beta-catenin protein in laryngeal squamous-cell carcinoma].[J]. Otolaryngologia Polska Polish Otolaryngol, 2004, 58(5):949-956.
[1] 肖俊华,潘庆春,晋舒. 基于全球疾病负担数据库分析职业硫酸暴露下喉癌患者的死亡趋势[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 55-61.
[2] 章娜娜,黄冠江,卢标清. 联合中医证型分析喉癌变的影响因素及构建预测模型[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 29-37.
[3] 刘丹凤,潘庆春,李代波,封雪飞,任健. 1990—2021年中国归因于过量饮酒的喉癌疾病负担分析及未来趋势预测[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 61-69.
[4] 谢枫,许贞菊,吴策,刘杰,臧传善,张龙宵,韩敏. 喉神经内分泌肿瘤26例临床病理特征及生存分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 79-86.
[5] 曲翔宇,朱晗,柳忠禄,牟亚魁,郭文涛,张华. 会厌舌瓣在喉癌声门上缺损修复术中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 77-84.
[6] 刘萍,顾子君,储婷,陈曦,程雷. 高流量呼吸湿化治疗仪在喉癌术后人工气道非机械通气患者中的应用效果研究[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 31-36.
[7] 王靖淞,余灿,张西,邓启成,谢卓良,赵锐,温蓓,刘海. KRT4在喉癌及癌旁正常黏膜组织中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2024, 38(3): 12-17.
[8] 张竹萍,叶琪,郭蓓,林凌. 叶酸受体阳性循环肿瘤细胞检测在喉鳞状细胞癌诊断中的应用价值[J]. 山东大学耳鼻喉眼学报, 2023, 37(5): 50-53.
[9] 张西,邓启成,张震,程瑶,王靖淞,赵锐,刘海. 营养支持对喉癌术后咽瘘影响的Meta分析[J]. 山东大学耳鼻喉眼学报, 2023, 37(3): 51-59.
[10] 徐翀,王晓亭,易红良. 单细胞测序分析喉癌及其微环境代谢相关靶基因[J]. 山东大学耳鼻喉眼学报, 2023, 37(2): 33-38.
[11] 黄恒丰,马鲲鹏,杨迪,张丽君,张盛林. miR-181b-5P和EPB41L3蛋白在喉癌中的表达及临床意义[J]. 山东大学耳鼻喉眼学报, 2023, 37(1): 41-46.
[12] 颜繁诚,蒋现,柴一杰,王昊森,孟照洋,汪晓磊,王艳玲,冯雪. miR-30-5p通过下调FOXG1表达抑制视网膜母细胞瘤细胞增殖[J]. 山东大学耳鼻喉眼学报, 2022, 36(5): 63-69.
[13] 李利杰,田秀芬. CO2激光联合低温等离子治疗早期声门型喉癌40例[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 79-85.
[14] 王媚 李志海. 喉癌干细胞:克服多药耐药性的潜在治疗靶点[J]. 山东大学耳鼻喉眼学报, 2022, 36(4): 120-128.
[15] 王晓亭,陈正侬,易红良. 利用RNA-seq探讨谷氨酰胺剥夺对喉癌细胞转录组的影响[J]. 山东大学耳鼻喉眼学报, 2022, 36(2): 26-31.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
网站版权所有 © 2018 《山东大学耳鼻喉眼学报》编辑部　
地址：山东省济南市山大南路27号（250100）电话：+86-0531-88366912 E-mail: ebhxb@sdu.edu.cn
本系统由北京玛格泰克科技发展有限公司设计开发